Skip to main content

Study Looks at Increasing Incidence of Pancreatic Cancer in Younger Adults

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 19, 2024.

By Elana Gotkine HealthDay Reporter

TUESDAY, Nov. 19, 2024 -- The increasing incidence of pancreatic cancer in young Americans is mainly due to increased detection of smaller, early-stage endocrine cancer, according to a research letter published online Nov. 19 in the Annals of Internal Medicine.

Vishal R. Patel, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues examined whether the observed increase in pancreatic cancer among young Americans represents a true increase in cancer occurrence by assessing the incidence, tumor size, stage distribution, and disease-specific mortality for pancreatic cancer among men and women aged 15 to 39 years.

The researchers found that the incidence of pancreatic cancer increased 2.1-fold in young women (3.3 to 6.9 per million) and 1.6-fold in young men (3.9 to 6.2 per million) between 2001 and 2019. In women and men, the rate of cancer-directed pancreatic surgery more than doubled (about 1.5 to 4.7 per million and about 1.1 to 2.3 per million, respectively). However, in both sexes, death from pancreatic cancer was stable (about 1.5 and 2.5 deaths per million for women and men, respectively). Early-stage cancer accounted for most of the increase in incidence (0.6 to 3.7 per million women and 0.4 to 2.2 per million men, respectively). The incidence of small tumors (≤2 cm) increased eightfold and threefold in women and men, respectively. The incidence of late-stage cancer did not change significantly in women or men. The increase in incidence was not due to adenocarcinoma; most of the increase was due to endocrine cancer and solid pseudopapillary neoplasms in women.

"The backdrop of stable mortality suggests that the recent increase in early-onset pancreatic cancer reflects detection of previously undetected disease rather than a true increase in cancer occurrence," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

2000 to 2021 Saw Increase in Incidence of Pancreatic Adenocarcinoma

WEDNESDAY, April 23, 2025 -- From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, according to a study...

Disparities Evident in Treatment, Survival for Patients With Pancreatic Cancer

THURSDAY, April 17, 2025 -- Among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC), racial and ethnic minority patients and socially vulnerable populations are...

Nanosensor Assay Promising for Pancreatic Cancer Detection

FRIDAY, Feb. 28, 2025 -- A rapid nanosensor assay that measures serum protease cleavage of a target-probe nanosensor can identify pancreatic ductal adenocarcinoma (PDAC) samples...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.